Display Settings:

Format

Send to:

Choose Destination
    AIDS. 2003 Oct 17;17(15):2267-9.

    The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

    Source

    YRG Centre for AIDS Research and Education, Chennai, India.

    Abstract

    We investigated the safety, tolerability and effectiveness of locally produced generic highly active antiretroviral therapy (HAART) regimens with a chart review conducted at YRG CARE, a tertiary HIV referral centre in India. A total of 333 patients had been on Indian-manufactured generic HAART for at least 3 months. In this cohort, generic HAART was safe, well tolerated and effective at increasing CD4 T-lymphocyte counts in patients with advanced HIV, comparable to the experience with proprietary HAART.

    PMID:
    14523288
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk